Last reviewed · How we verify

NCT06636929

Effect of Problematic Smartphone Use

Completed Last updated 10 March 2026
What this trial tests

trial in Smartphone Addiction in 131 participants. Completed in 31 December 2025.

Timeline
20 October 2024
Primary endpoint
30 June 2025
31 December 2025

Quick facts

Lead sponsorKutahya Health Sciences University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment131
Start date20 October 2024
Primary completion30 June 2025
Estimated completion31 December 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Kutahya Health Sciences University

Who can join

Adults 18 to 25, any sex, with Smartphone Addiction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is no study that examines the effect of problematic use of smartphones, which has become a global problem today, on reaction time and cognitive functions together. This study was planned to examine the effect of problematic smartphone use on upper extremity functions and cognitive functions. Participants' problematic smartphone use will be evaluated with the Smartphone Addiction Scale Short Form. Within the scope of upper extremity functions, Quick Disabilities of Arm, Shoulder \& Hand Questionnaire, reaction time and grip strength will be evaluated. Reaction time will be measured with BlazePod Trainer (Blazepod Trainer Device, Play Coyotta Ltd, Tel Aviv, Israel). Jamar dynamometer (Performance Health, Warrenville, IL) will be used to evaluate grip strength. Cognitive functions will be assessed using the Stroop Test ÇAPA Form, Trail Making Test and Cognitive Failures Questionnaire.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Smartphone Addiction

Currently open trials in the same condition.

Other Kutahya Health Sciences University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06636929.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing